From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma - Top-Institutions - MDSpire

From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma

  • By

  • Jean-Baptiste Barbe-Richaud

  • Hélène Cebula

  • Julien Todeschi

  • Marie des Neiges Santin

  • Seyyid Baloglu

  • Roland Schott

  • Mathieu Cotton

  • Aurélien Blouet

  • Maxime Bobin

  • Georges Noël

  • Laura Somme

  • June 23, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Institut de Cancérologie Strasbourg Europe
    Institut de Cancérologie Strasbourg Europe

    Strasbourg, Grand Est

    Key Differentiators

    • Oncology

  • #2

    Centre d’Oncologie du Pays Basque
    Centre d’Oncologie du Pays Basque

    Bayonne, Nouvelle-Aquitaine

    Key Differentiators

    • Oncology

  • #3

    VU University Medical Center Amsterdam
    VU University Medical Center Amsterdam

    Amsterdam, North Holland

    Key Differentiators

    • Oncology

Original Source(s)

From relapse to survival: real-world clinical impact of a multimodal approach in first-time recurrent glioblastoma

  • by Jean-Baptiste Barbe-Richaud, Hélène Cebula, Julien Todeschi, Marie des Neiges Santin, Seyyid Baloglu, Roland Schott, Mathieu Cotton, Aurélien Blouet, Maxime Bobin, Georges Noël, Laura Somme

  • June 23, 2026

Related Content

Liquid Biopsy in Pediatric Acute Lymphoblastic Leukemia (ALL)

Editorial: Precision oncology: integrating molecular mechanisms, organoid models, and omics technologies for personalized cancer care

Prostatic incidental uptake on PET/CT: an updated systematic review and meta-analysis of prevalence and malignancy risk